Previous Article | Next Article 
Infection and Immunity, April 1999, p. 1736-1742, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Lipopolysaccharides (LPS) of Oral Black-Pigmented Bacteria Induce
Tumor Necrosis Factor Production by LPS-Refractory C3H/HeJ Macrophages
in a Way Different from That of Salmonella LPS
Teruo
Kirikae,1,*
Toshimasa
Nitta,2
Fumiko
Kirikae,1
Yasuo
Suda,3
Shoichi
Kusumoto,3
Nirofer
Qureshi,4 and
Masayasu
Nakano1
Department of Microbiology, Jichi Medical
School, Tochigi-ken 329-0498,1
Department of Bacteriology, Ohu University School of
Dentistry, Koriyama 963-8611,2 and
Faculty of Science, Osaka University, Toyonaka
560-0043,3 Japan, and Mycobacterial Research
Laboratory, William S. Middleton Memorial Veterans Hospital,
Madison, Wisconsin 537064
Received 10 September 1998/Returned for modification 24 November
1998/Accepted 20 January 1999
 |
ABSTRACT |
Some lipopolysaccharide (LPS) preparations from S- or R-form
members of the family Enterobacteriaceae and oral
black-pigmented bacteria (Porphyromonas gingivalis and
Prevotella intermedia) are known to activate
LPS-refractory C3H/HeJ macrophages. When contaminating
proteins are removed from R-form LPS of
Enterobacteriaceae by repurification, however, this
ability is lost. In the present study, we investigated the capacity of
LPS from P. gingivalis, P. intermedia,
Salmonella minnesota, and Salmonella
abortusequi to induce production of tumor necrosis
factor (TNF) in gamma interferon-primed C3H/HeJ macrophages
before and after repurification. P. abortusequi S-LPS was fractionated by centrifugal partition
chromatography into two LPS forms: SL-LPS, having homologous long
O-polysaccharide chains, and SS-LPS having short oligosaccharide
chains. Prior to repurification, all LPS forms except SL-LPS induced
TNF production in both C3H/HeJ and C3H/HeN macrophages.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that
repurification removed contaminating protein from the preparations, and
repurified SS-LPS and S. minnesota Ra-LPS no
longer stimulated TNF production in C3H/HeJ
macrophages, although C3H/HeN macrophages remained
responsive. In contrast, repurified oral bacterial LPS retained the
capacity to induce TNF production in C3H/HeJ macrophages.
Oral bacterial LPS preparations also were not antagonized by
excess inactive, repurified SL-LPS; Ra-LPS; Rhodobacter
sphaeroides lipid A, a competitive LPS antagonist, or paclitaxel,
an LPS agonist, and they were comparatively resistant to polymyxin B
treatment. Nevertheless, oral bacterial LPS was less toxic to
D-galactosamine-treated C3H/HeN mice than was LPS from
Salmonella. These findings indicate that the active
molecule(s) and mode of action of LPS from P. gingivalis
and P. intermedia are quite different from those of LPS
from Salmonella.
 |
INTRODUCTION |
C3H/HeJ is a unique mutant
mouse strain derived from C3H/He mice. As a result of a genetic
defect, they lack the ability to respond to endotoxin or
lipopolysaccharide (LPS) derived from the cell walls of gram-negative
bacteria or the lipid A component thereof (reviewed in reference
25). A recent study demonstrated that the mutation
of C3H/HeJ mice is located in the Tlr4 gene (30). While C3H/HeJ cells are profoundly refractory to
some highly purified LPS, however, the cells remain responsive to other endotoxins (e.g., Boivin) in which the endotoxin protein or lipid A-associated protein (35) is known to be bioactive. In
addition, LPS from Brucella abortus (21,
33), Pseudomonas aeruginosa (29),
Porphyromonas (Bacteroides)
gingivalis (5, 7), and Bacteroides
fragilis (12) are also known to activate C3H/HeJ cells. LPS isolated from rough (R-form) mutant members of the family Enterobacteriaceae had also been thought capable of
stimulating C3H/HeJ cells, but Manthey and Vogel (19)
clearly demonstrated that the effect disappeared when protein
associated with the LPS was removed by repurification.
P. gingivalis and Prevotella intermedia are
the dominant gram-negative bacteria in the periodontal
pockets of patients with periodontitis, and they are considered
to be the major pathogens associated with periodontal diseases
(38, 41). LPS of P. gingivalis and P. intermedia has been suggested as a possible virulence factor, acting by stimulation of host cells to induce production of
proinflammatory mediators (28). Their LPS possess
unique chemical and biological properties different from those of LPS
of Enterobacteriaceae (15-17, 27, 28). The low
endotoxic activity of P. gingivalis LPS has been suggested
to be due to the unique chemical structure of its lipid A (15,
27).
LPS from wild type (S-form) organisms of
Enterobacteriaceae is a glycolipid complex composed of
three distinct structural elements: an O-antigenic repeating
polysaccharide, a core oligosaccharide, and a lipophilic
component designated lipid A. Wild-type strains synthesize LPS with
long polysaccharide chains, the so-called S-form LPP.
In R-form strains, biosynthesis of the O polysaccharide and, in
some cases, the core oligosaccharide is defective. Consequently, R-form strains synthesize LPS, generally termed R-chemotype or R-form LPS, with shorter saccharide chains. As it happens, during cell wall biosynthesis, S-form bacteria also produce incomplete, R-form LPP. We previously showed that the native S-form
LPS from Salmonella abortusequi contains both S-form
(SL-LPS) and R-form (SS-LPS) LPS which were separable by
centrifugal partition chromatography (CPC) and that their respective
endotoxicities, as assessed by macrophage activation, were
quite different (34). In the present study, we set out to
clarify whether SL- and SS-LPS are capable of inducing
C3H/HeJ macrophages to produce tumor necrosis factor (TNF),
and if so, whether the active principle can be removed by
repurification by the method of Manthey and Vogel (19). We also determined whether LPS isolated from the oral bacteria P. gingivalis and Prevotella intermedia retain the
capacity to induce TNF production in C3H/HeJ macrophages
after repurification.
 |
MATERIALS AND METHODS |
Mice.
C3H/HeN and C3H/HeJ mice were bred and
maintained in the Animal Faculty of the Jichi Medical School under
standard care. Female mice were used at 8 to 12 weeks of age. In
individual experiments, age-matched mice were used.
LPS.
LPS from P. gingivalis 381 and
P. intermedia ATCC 25611 were prepared by using a hot
phenol-water extraction procedure (40). LPS of
Rhodobacter sphaeroides ATCC 17023 (RsDPLA) was prepared as
previously described (32). Ra-chemotype LPS (Ra-LPS) from Salmonella minnesota R595 was kindly provided by K. Hisatsune, Josai University, Sakado, Japan. Ra-LPS from
S. minnesota R60 was obtained from List Biological
Laboratories, Inc., Campbell, Calif. S-form LPS from Escherichia
coli O111:B4, S. abortusequi, and wild-type
S. minnesota were purchased from Sigma Chemical Co., St. Louis, Mo.
Reagents.
Polymyxin B and paclitaxel (Taxol) were obtained
from Sigma Chemical Co. Murine recombinant gamma interferon (IFN-
)
was provided by Shionogi Pharmaceutical Co., Osaka, Japan.
Fractionation of wild-type LPS into LPS with and without
O-polysaccharides.
LPS isolated from wild-type S. abortusequi is actually a mixture of two LPS forms: SL-LPS, having
homologous long O-polysaccharide chains, and SS-LPS, which, like
R-form LPS, lacks most O-saccharide chains. The two LPS
preparations were isolated from each other by CPC as previously
described (34). Briefly, the triethylamine (TEA) salt of LPS
from S. abortusequi (10 mg) was applied to a Sanki
LLB-M CPC apparatus (Sanki Engineering, Kyoto, Japan) being used with a
solvent system consisting of
1-butanol-tetrahydrofuran-methanol-water (10/7/1/20, vol/vol) at
25°C and 1,900 rpm. The fractions were then separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
visualized by silver staining. Fractions rich in SL- and SS-LPS were
respectively pooled and used for experiments as SL-LPS and
SS-LPS. Dry-weight recoveries for the pooled fractions were
45 and 17%, respectively.
Repurification of LPS using a modified phenol-water extraction
procedure.
Ra-LPS, P. gingivalis LPS, P. intermedia LPS, SL-LPS, and SS-LPS were repurified by
detergent-modified phenol-water extraction as described by Manthey and
Vogel (19). Briefly, LPS was suspended in H2O (5 mg of LPS/ml) containing 0.2% TEA and 0.5% sodium deoxycholate, and
the sample (1 vol) was extracted with an equal volume of a 9:1 (wt/wt)
phenol-water solution. The phenol phase was then re-extracted with 1 volume of H2O containing 0.2% TEA and 0.5% sodium
deoxycholate, and the aqueous phase was re-extracted with 1 volume of
9:1 (wt/wt) phenol-water. The aqueous phase was then adjusted to 75%
ethanol and 30 mM sodium acetate, and the LPS was allowed to
precipitate at
20°C for 1 h. Recovery of Salmonella
LPS in the aqueous phase was determined by measuring
3-keto-3-deoxyocturonic acid.
Analysis of LPS and protein by SDS-PAGE.
As described
by Manthey and Vogel (19), diluted samples were boiled for 5 min with 0.33 volume of 4× loading buffer. LPS was then resolved by
SDS-13% PAGE and visualized by silver staining in accordance with the
manufacturer's (Bio-Rad Laboratories, Richmond, Calif.) instructions.
The resolved proteins were blotted onto nitrocellulose transfer
membranes and stained in colloidal gold solution for 1 h (Bio-Rad
Laboratories). The molecular weights of the endotoxin proteins were
determined by comparison with known protein standards (Low Molecular
Weight Range Molecular Weight Markers; Bio-Rad Laboratories).
Macrophage isolation and culture.
Murine peritoneal
macrophages were isolated by peritoneal lavage 4 days after
intraperitoneal (i.p.) injection of 1.5 ml of 3% Brewer thioglycolate
broth (Difco Laboratories, Detroit, Mich.). The cells were washed with
serum-free RPMI 1640 medium (ICN Biomedicals, Costa Mesa, Calif.)
containing 4 mM L-glutamine, 100-U/ml penicillin, and
100-µg/ml streptomycin and plated in 96-well plates (Nunc, Roskilde,
Denmark) at a concentration of 2 × 105 cells/well.
After the cells had been incubated for 2 h at 37°C under an
atmosphere of 95% air-5% CO2, they were washed with
serum-free RPMI 1640 medium to remove nonadherent cells. The remaining
cells were incubated for an additional 3.5 h in the presence of
various doses of LPS in 200 µl of RPMI 1640 medium also
containing (i) 2% heat-inactivated fetal bovine serum (JRH
Biosciences, Lenexa, Kans.) in the case of C3H/HeN
macrophages or (ii) 2% heat-inactivated fetal bovine serum
plus 20-U/ml murine recombinant IFN-
in the case of C3H/HeJ
macrophages. After the incubation period, the culture
supernatants were collected for TNF assay. Contaminating endotoxin
concentrations in culture media and serum was quantified by using a
modified Limulus amebocyte lysate test (Endospeci Test Kit;
Seikagaku Corporation, Tokyo, Japan), and found to be 4.8 and 2.4 pg/ml, respectively.
TNF bioassay.
Culture supernatants were assayed for TNF
bioactivity in a standard cytotoxicity assay using actinomycin
D-treated L929 cells as described previously (13).
Determination of LD50 for mice.
Groups of
C3H/HeN mice (four to eight per group) were simultaneously injected
i.p. with GalNac (18 mg/mouse) and LPS (0.1 ng to 10 µg/mouse).
Mortality was scored 72 h after injection, and the 50% lethal
dose (LD50) was calculated by the method of Reed and Muench.
 |
RESULTS |
SDS-PAGE following CPC fractionation and repurification of
S. abortusequi LPS.
As expected,
SDS-PAGE of Westphal-type LPS (40) prepared from wild-type
S. abortusequi resolved two distinct bands
revealing the presence of two LPS molecules (Fig.
1, left panel, lane 3): a relatively
broad band with a higher molecular weight (SL-LPS) and a relatively
narrow band with a lower molecular weight (SS-LPS). SL-LPS and SS-LPS
were subsequently separated by CPC (Fig. 1, left panel, lanes 4 and 6).
S. minnesota Ra-LPS was extracted in
phenol-chloroform-petroleum ether (9) and had a molecular weight comparable to that of SS-LPS (Fig. 1, left panel, lane 1).
Repurification of the isolated Ra-LPS, SL-LPS, and SS-LPS using a
modified phenol-water extraction procedure had no further effect on the
gels (Fig. 1, left panel, lanes 2, 5, and 7).

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 1.
SDS-PAGE and Western blot analysis of P. minnesota Ra-LPS and S. abortusequi
LPS. S. abortusequi S-form LPS was
fractionated into SL-LPS and SS-LPS by CPC. Some preparations were
repurified by a modified phenol-water extraction procedure. The LPS
were submitted to SDS-13% PAGE, and the gels were visualized by
silver staining (left panel). Proteins were blotted onto nitrocellulose
and stained with colloidal gold (right panel). Lanes: 1, Ra-LPS (0.8 µg); 2, repurified Ra-LPS (0.8 µg); 3, S. abortusequi LPS (2.5 µg); 4, SL-LPS (1.5 µg); 5, repurified
SL-LPS (1.5 µg); 6, SS-LPS (0.8 µg); 7, repurified SS-LPS (0.8 µg). MW, molecular mass.
|
|
Another set of SDS-PAGE blots were stained with colloidal gold in order
to detect protein. As shown in the right panel of Fig. 1, Ra-LPS
possessed a major protein component with a molecular mass of 41 kDa.
After repurification, however, that protein had disappeared. Other LPS
species showed no trace of proteins including the 41-kDa protein before
or after repurification.
LPS-induced TNF production in C3H/HeJ macrophages.
C3H/HeJ macrophages are known to be refractory to S-form
LPS extracted by the phenol-water procedure (40), although
if cultured in the presence of IFN-
(1, 3), they may
respond to LPP. Indeed, we have at times observed that
phenol-water-extracted S-form LPS stimulates TNF production in
IFN-
-primed, C3H/HeJ macrophages. Therefore, six
preparations of commercially available phenol-water-extracted S-form
LPS from S. abortusequi were tested for the
capacity to induce TNF production in IFN-
-primed C3H/HeJ macrophages. At a concentration of 1 µg/ml, four of the LPS
preparations elicited marginal levels of TNF synthesis (<100 U/ml),
whereas two of the preparations were significantly more efficacious and elicited synthesis of >500-U/ml TNF.
Activation of C3H/HeJ macrophages by SS-LPS and SL-LPS
before and after repurification.
One of the two aforementioned
S. abortusequi LPS capable of activating
IFN-
-primed C3H/HeJ macrophages was fractionated into SS- and SL-LPS, and samples of the respective fractions, as well as
samples of Ra-LPS, were then repurified by phenol-water extraction. Their capacities to induce TNF production in IFN-
-primed C3H/HeJ or unprimed C3H/HeN macrophages were then assessed. Prior
to repurification, SS-LPS and Ra-LPS each stimulated IFN-
-primed
C3H/HeJ macrophages, although that capacity was lost when
the LPS preparations were repurified (Fig.
2A); SL-LPS lacked the ability to induce
TNF production both before or after repurification. In contrast, all three LPS preparations induced TNF production in C3H/HeN
macrophages, regardless of repurification (Fig. 2B).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 2.
TNF production induced by SS-LPS and SL-LPS before and
after repurification in C3H/HeN and C3H/HeJ
macrophages. C3H/HeJ macrophages were pretreated
with IFN- (20 U/ml) for 2 h. C3H/HeJ (A) and C3H/HeN
(B) macrophages were then incubated with the indicated doses of
SS-LPS, SL-LPS, or Ra-LPS for 4 h in triplicate wells. TNF
activity in the supernatants was determined by cytotoxicity
assay using L929 cells. TNF secretion by unstimulated cells was below
detectable levels in all experiments. Filled circles indicate LPS
without repurification, and open circles indicate repurified LPS
(assuming 100% recovery of LPS after repurification). Each point
represents the mean ± the standard error. The data are from
one of two independent experiments with similar results.
|
|
Effect of repurification on SDS-PAGE and induction of TNF by LPS
from P. intermedia and P. gingivalis.
LPS from
some strains of oral bacteria are known to activate C3H/HeJ
and C3H/HeN cells (5, 7). Prior to repurification, LPS
obtained from P. intermedia and P. gingivalis by phenol-water extraction as well as Ra-LPS induced
TNF production in both C3H/HeJ and C3H/HeN
macrophages (Fig. 3A and B).
Moreover, all but Ra-LPS remained active even after repurification,
although TNF production induced by repurified P. gingivalis LPS decreased slightly (Fig. 3B). With respect to
C3H/HeJ macrophages, the capacity to elicit TNF production
was retained by repurified LPS from P. intermedia and
P. gingivalis but was entirely absent from
repurified Ra-LPS (Fig. 3A). SDS-PAGE carried out before and after
repurification revealed no remarkable changes in gels visualized
with silver stain (data not shown). On the other hand, gels
stained with colloidal gold confirmed that the protein component in
Ra-LPS was lost during repurification (data not shown).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of repurification of TNF production induced by
P. intermedia LPS, P. gingivalis LPS,
and Ra-LPS. C3H/HeJ macrophages were pretreated with
IFN- (20 U/ml) for 2 h. C3H/HeJ (A) and C3H/HeN (B)
macrophages were incubated for 4 h with the indicated
doses of P. intermedia LPS, P. gingivalis LPS, or Ra-LPS. TNF activity in the supernatants was
then determined by cytotoxicity assay using L929 cells. TNF secretion
by unstimulated cells was below detectable levels in all experiments.
Filled circles indicate LPS without repurification, and open circles
indicate repurified LPS. The doses of repurified LPS are based on the
intensity of silver staining in SDS-PAGE. The yields of LPS during
repurification were more than 80%. The data are from one of two
independent experiments with similar results.
|
|
Antagonistic effect of repurified Ra-LPS and SS-LPS on
LPS-induced TNF production.
Repurified Ra-LPS and SS-LPS were
incapable of eliciting TNF production in IFN-
-primed C3H/HeJ
macrophages, even at a concentration of 10 µg/ml. We were
interested to know, therefore, whether these repurified, inactive LPS
would interfere with TNF production elicited by other active LPS in
IFN-
-primed C3H/HeJ macrophages. We observed that
repurified, inactive Ra-LPS (Fig. 4A) and
SS-LPS (Fig. 4B) each dose dependently inhibited TNF production
elicited by their nonrepurified counterparts. In contrast, the inactive
LPS failed to inhibit TNF production induced by P. intermedia LPS and P. gingivalis LPP.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 4.
Inhibitory effect of repurified Ra-LPS and SS-LPS on
LPS-induced TNF production in IFN- -primed C3H/HeJ
macrophages. C3H/HeJ macrophages were pretreated
with IFN- (20 U/ml) for 2 h and then cultured for an additional
2 h in the presence or absence of the indicated doses of
repurified Ra-LPS (A) or SS-LPS (B). TNF production was then
elicited by addition of 10-ng/ml Ra-LPS, SS-LPS, or
P. intermedia LPS or 100-ng/ml P. gingivalis LPS (open circles) and incubation for 4 h. TNF
activity in the supernatants was determined by cytotoxicity assay using
L929 cells. As a negative control (closed circles), some cultures were
exposed only to repurified Ra-LPS (A) or SS-LPS (B). TNF secretion by
unstimulated cells was below detectable levels in all experiments. Each
point represents the mean ± the standard error of triplicate
cultures. The data are from one of two independent experiments with
similar results.
|
|
Taken together, the data presented so far strongly suggest that the
active molecules present in LPS from oral bacteria differ
substantially
from those present in Ra-LPS and SS-LPP.
Effect of RsDPLA and paclitaxel on TNF production
induced by P. intermedia LPS, P. gingivalis LPS, Ra-LPS, and SS-LPP.
RsDPLA, an LPS from
R. sphaeroides, is known to be a specific LPS antagonist and
has been shown to inhibit a variety of LPS-evoked responses in
macrophages (18). For instance, LPS-induced TNF production in macrophages is specifically blocked by RsDPLA, as is the binding of 125I-labelled LPS (13).
Conversely, paclitaxel is an LPS-like agonist (6, 20): it
stimulates TNF production in murine macrophages but has little
effect on LPS-refractory C3H/HeJ macrophages. The present experiments were carried out to determine the effects of
RsDPLA and paclitaxel on TNF production elicited by P. intermedia LPS, P. gingivalis LPS, Ra-LPS, and
SS-LPS in C3H/HeN and IFN-
-primed C3H/HeJ
macrophages. RsDPLA and paclitaxel were each added to separate
cultures 1 h before LPP.
As shown in Fig.
5, TNF production
elicited by LPS from
P. intermedia and
P. gingivalis was not suppressed by RsDPLA, whereas
RsDPLA dose
dependently inhibited the TNF production elicited
by Ra-LPS and
SS-LPP. Paclitaxel had no effect on LPS-induced
TNF production in
IFN-

-primed C3H/HeJ macrophages, although higher
doses
of dimethyl sulfoxide, the vehicle used to dissolve paclitaxel,
appeared to suppress TNF production somewhat (Fig.
6, open circles).

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 5.
Antagonistic effect of RsDPLA on TNF production induced
by Ra-LPS, SS-LPS, P. intermedia LPS, and P. gingivalis LPP. INF- -primed C3H/HeJ (A) and unprimed
C3H/HeN (B) macrophages and were incubated with the
indicated doses of RsDPLA for 1 h, and then Ra-LPS (10 ng/ml),
SS-LPS (10 ng/ml), P. intermedia LPS (10 ng/ml), and
P. gingivalis LPS (100 ng/ml) were added to respective
cultures, which were then incubated for 4 h. TNF activity in the
supernatants was then determined by cytotoxicity assay. Open bars, LPS
without repurification; dotted bars, repurified LPP. Bars depict
means ± the standard errors of triplicate cultures. The data are
from one of two independent experiments with similar results.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 6.
Effect of paclitaxel on LPS-induced TNF production in
IFN- -primed C3H/HeJ macrophages. C3H/HeJ
macrophages were pretreated for 2 h with IFN- (20 U/ml)
and then incubated with the indicated doses of paclitaxel for 1 h
(filled circles). As a control, some cultures received equivalent
amounts of the vehicle (dimethyl sulfoxide; open circles). The
macrophages were cultured in the presence or absence of
unrepurified Ra-LPS (10 ng/ml), SS-LPS (10 ng/ml), P. intermedia LPS (10 ng/ml), or P. gingivalis LPS
(100 ng/ml) for 4 h, and then TNF activity in the supernatants was
determined by cytotoxicity assay. Each point represents the mean ± the standard error. The data are from one of two independent
experiments with similar results.
|
|
Sensitivity of P. intermedia LPS, P. gingivalis LPS, Ra-LPS, and SS-LPS to polymyxin B.
Polymyxin
B neutralizes many of the biological activities of LPS by binding to
lipid A (22, 23). We tested the sensitivity of repurified
preparations of P. intermedia LPS, P. gingivalis LPS, and nonrepurified Ra-LPS and SS-LPS to polymyxin
B. High or low concentrations of these preparations were incubated with various doses of polymyxin B; the mixtures were then added to C3H/HeN or C3H/HeJ macrophage cultures, and evoked TNF
production was assessed (Fig. 7).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 7.
Effect of polymyxin B on TNF production induced by
P. intermedia LPS, P. gingivalis LPS,
Ra-LPS, or SS-LPP. High (1,000 and/or 100 ng/ml) or low (10 ng/ml)
concentrations of repurified P. intermedia and
P. gingivalis LPS and unrepurified Ra-LPS and SS-LPS
were incubated for 30 min with the indicated doses of polymyxin B. The
polymyxin B-LPS mixture was added to INF- (20 U/ml)-primed
C3H/HeJ (A) or unprimed C3H/HeN (B) macrophages, which
were then incubated for 4 h, and then TNF activity in the
supernatants was determined by cytotoxicity assay. The bars depict the
means ± the standard errors of triplicate cultures. The data are
from one of two independent experiments with similar results.
|
|
In C3H/HeN macrophage cultures, increasing doses of
polymyxin B suppressed the TNF production elicited by both high (100 ng/ml)
and low (10 ng/ml) doses of Ra-LPS and SS-LPS (Fig.
7B, left
panels),
as well as by low doses (10 ng/ml) of
P. intermedia LPS and
P. gingivalis LPS (Fig.
7B,
right panels). On the other hand, polymyxin
B did not attenuate the TNF
production induced by high doses of
P. intermedia LPS
and
P. gingivalis LPS (100 and 1,000 ng/ml,
respectively; Fig.
7B, right panels). Similar results were obtained
with IFN-

-primed C3H/HeJ macrophages, although the
magnitude
of the polymyxin B-evoked inhibition was somewhat
smaller (Fig.
7A). Thus,
P. intermedia LPS and
P. gingivalis LPS were apparently
substantially less
sensitive to polymyxin B than were Ra-LPS and
SS-LPP.
Lethal toxicity of LPS from oral bacteria in GalNac-loaded
C3H/HeN mice.
Since P. gingivalis LPS always
appeared less efficacious than P. intermedia LPS, we
examined the toxicity of repurified preparations of these LPS in
GalN-loaded C3H/HeN mice (8). Consistent with its
greater ability to induce TNF production, P. intermedia
proved to be more toxic than P. gingivalis; indeed,
P. gingivalis LPS was nontoxic (Table 1). Overall, we
found the following toxicity order: Ra-LPS > P. intermedia LPS >> P. gingivalis LPP. Groups of
C3H/HeN mice (four to eight per group) were simultaneously injected
i.p. with GalN (18 mg/mouse) and various doses (0.01 ng to
10 µg/mouse) of repurified LPP. Mortality was scored
72 h after the challenge. The LD50s calculated by the
method of Reed and Muench were as follows: S. minnesota Ra-LPS, 1.15 ng; P. intermedia LPS,
14.5 ng; P. gingivalis LPS, >10,000 ng.
 |
DISCUSSION |
In an earlier study (34), we used CPC to show that
S-form S. abortusequi LPS could be
fractionated into SL-LPS having long, S-form O-polysaccharide
chains and SS-LPS having short, R-form oligosaccharide
chains. SL-LPS and SS-LPS also differed in the ability to induce TNF
production in murine macrophage-like J774.1 cells: SS-LPS
induced TNF production in serum-free culture medium, whereas
SL-LPS required the presence of serum in the culture medium (34).
LPS-refractory C3H/HeJ and C57BL/10ScCr mice, as well as the cells
isolated from them, are known to be generally unresponsive to LPS from
Enterobacteriaceae (e.g., E. coli and
Salmonella), although they are sometimes responsive to
R-form LPS (reviewed in reference 25). In
addition, macrophages from Mycobacterium bovis
BCG-infected C3H/HeJ mice (26) and uninfected
C3H/HeJ macrophages cultured in the presence of either
IFN-
(1, 3) or the calcium ionophore A23187 (1,
26) are responsive to LPP. IFN-
enhances LPS-induced TNF
production by augmenting the transcription rate and stability of TNF
mRNA (11). Priming of C3H/HeJ macrophages with
IFN-
also appears to facilitate the "decision" of
macrophages to respond to LPS.
Manthey and Vogal (19) showed that the ability of LPS to
activate LPS-refractory mice and their cells disappeared when the LPS was repurified and contaminating protein was removed. In the present study, although repurification did not affect TNF
induction in LPS-responsive C3H/HeN macrophages, it
completely blocked the ability of SS-LPS and Ra-LPS to activate
IFN-
-primed, LPS-refractory C3H/HeJ macrophages (Fig.
2A). Combined with the effect of repurification on colloidal gold
staining of SDS-PAGE gels (Fig. 1, right panel), these results
strongly suggest that a protein associated with SS-LPS and Ra-LPS
is necessary for activation of IFN-
-primed C3H/HeJ
macrophages; most likely, the active molecule is a lipid A-associated protein, as described by Manthey and Vogel
(19).
LPS from both P. gingivalis and P. fragilis, as well as lipid A-associated protein, are known to
activate cultured cells isolated from LPS-refractory C3H/HeJ and
C57BL/10ScCr mice (5, 7, 39), and evidence suggests that
activation of LPS-refractory C3H/HeJ mice by P. gingivalis LPS is specifically mediated by the lipid A portion of
LPS (37). We nonetheless observed that LPS from
P. gingivalis and P. intermedia were
capable of inducing TNF production in C3H/HeJ and C3H/HeN
macrophages even after repurification and, presumably,
removal of lipid A-associated protein. The responses were
somewhat weakened, however, especially in the case of P. gingivalis LPS (Fig. 3). LPS derived from P. gingivalis possesses chemical constituents different from those
derived from Enterobacteriaceae, including the core
saccharide region of the LPS (16, 17), as well as the lipid
A portion (16, 27). The chemical structure of the
lipid A of P. gingivalis is characterized by the
absence of ester-linked phosphate at the 4' position of glucosamine
disaccharide and the presence of fatty acids possessing
considerable lengths of acyl chains (16, 27). Thus, in
contrast to activation by Ra-LPS and SS-LPS, activation of
C3H/HeJ macrophages by LPS from P. intermedia and P. gingivalis is apparently
elicited by the LPS with unique structures themselves and not by lipid
A-associated protein. In other words, the chemical configuration and/or
the mode of action of the active entity in P. intermedia and P. gingivalis LPS is quite
different from that of the active entity in Ra-LPS and SS-LPP.
Furthermore, the fact that Ra-LPS was more potent against
C3H/HeN than C3H/HeJ macrophages (Fig. 2) is
consistent with the idea that an impurity activates C3H/HeJ
macrophages. Conversely, the equipotency of P. intermedia and P. gingivalis LPS against
C3H/HeJ and C3H/HeN macrophages is consistent with the
idea that the LPS is the stimulant for both cells. These results also
support our conclusion that the active molecular part is the
lipid A portion of P. intermedia and P. gingivalis LPS and that its mode of action against
macrophages is apparently different from those of Ra-LPS.
Unique aspects of the effect of P. intermedia and
P. gingivalis LPS on C3H/HeJ
macrophages were also made manifest by competitive binding experiments using repurified Ra-LPS, repurified SS-LPS, and
RsDPLA. Repurified Ra-LPS and SS-LPS did not antagonize the actions of
LPS from P. intermedia and P. gingivalis, although they competed with their nonrepurified
counterparts (Fig. 4). Moreover, RsDPLA, which competitively
antagonizes LPS receptor binding (10, 13, 14, 18, 31, 36),
dose dependently inhibited TNF production elicited by Ra-LPS and
SS-LPS, but it did not antagonize the actions of P. intermedia or P. gingivalis LPS (Fig. 5),
suggesting that macrophage receptors for P. intermedia and P. gingivalis LPS are different
from those for RsDPLA, Ra-LPS, and SS-LPP.
The chemical structure of paclitaxel, which is clinically used as an
anticancer drug, is very much unlike that of LPP. Interestingly, paclitaxel induced RsDPLA-sensitive TNF production in C3H/HeN macrophages, yet 3H-labelled paclitaxel
binding to macrophages was not inhibited by LPS or RsDPLA
(13), which suggests that the receptor for paclitaxel is
different from that for LPS but is located very close to the LPS
receptor. The findings of the present study are consistent with that
notion, since paclitaxel had little or no effect on the actions of
Ra-LPS, SS-LPS, P. intermedia LPS, and P. gingivalis LPS (Fig. 6).
Polymyxin B destroys the biological activity of LPS and lipid A
isolated from Enterobacteriaceae (e.g., E. coli and Salmonella spp. [24]). We
found that pretreating Ra-LPS or SS-LPS with polymyxin B completely
blocked their ability to elicit TNF production in either
C3H/HeN or C3H/HeJ macrophages. By contrast, LPS from P. intermedia and P. gingivalis were
relatively resistant to polymyxin B (Fig. 7). The polysaccharides and
fatty acids of P. gingivalis LPS are certainly unlike
those of LPS from Enterobacteriaceae (reviewed in reference
5), and this likely underlies their resistance
to polymyxin B. In addition, the observation that when LPS was present
at higher concentrations it was more resistant to polymyxin B than when
it was present at lower concentrations suggests that both polymyxin
B-sensitive and polymyxin B-resistant endotoxic molecules are present
in P. gingivalis LPS. If so, when a low dose of LPS
containing a lesser amount of a polymyxin B-resistant molecule is
treated with polymyxin B, the quantity of active endotoxic molecules
remaining might not be sufficient to elicit a peak response. On
the other hand, at the higher concentration, the number of active
molecules may be sufficient to elicit robust responses even in
the presence of polymyxin B. This hypothesis, however, remains to be tested.
TNF production induced in C3H/HeN macrophages by oral
bacterial LPS was similar to that elicited by Ra-LPS (Fig. 3B). TNF is
thought to be one of the major causative factors in endotoxic shock and
death (23). However, the lethal toxicities in
GalNac-sensitized mice of the LPS examined in this study were not
consistent with that picture (see Results). Ra-LPS was toxic, but
P. intermedia LPS was substantially less so and
P. gingivalis LPS was nontoxic. Given their efficacy
with respect to induction of TNF synthesis, we do not know the reason
why injection of P. intermedia LPS or P. gingivalis LPS did not cause endotoxic shock. However, shock is a
complex phenomenon entailing activation of complement, coagulation, fibrinolytic, and kinin pathways and resulting in release of vasoactive peptides and an array of cytokine mediators, including TNF,
interleukin-1 (IL-1), IL-6, IL-8, and nitric oxide from
macrophages and other cell types (4, 23). The
released mediators, in turn, trigger the characteristic
biological effects. Endotoxic shock and death would, therefore,
result from the integrated action of all of these mediators rather than
that of TNF alone (2).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Jichi Medical School, 3311-1 Yakushiji,
Minamikawachi-machi, Tochigi-ken 329-0498, Japan. Phone: 81 285 58 7332. Fax: 81 285 44 1175. E-mail: tkirikae{at}jichi.ac.jp.
Editor:
J. R. McGhee
 |
REFERENCES |
| 1.
|
Akagawa, K. S.,
K. Kamoshita,
S. Onodera, and T. Tokunaga.
1987.
Restoration of lipopolysaccharide-mediated cytotoxic macrophage induction in C3H/HeJ mice by interferon- or a calcium ionophore.
Jpn. J. Cancer Res.
78:279-287[Medline].
|
| 2.
|
Amura, C. R.,
L. C. Chen,
N. Hirohashi,
M. G. Lei, and D. C. Morrison.
1997.
Two functionally independent pathways for lipopolysaccharide-dependent activation of mouse peritoneal macrophages.
J. Immunol.
159:5079-5083[Abstract].
|
| 3.
|
Beutler, B.,
V. Tkacenko,
I. Milsark,
N. Krochin, and A. Cerami.
1986.
Effect of -interferon on cachectin expression by mononuclear phagocytes: reversal of the Lpsd (endotoxin resistance) phenotype.
J. Exp. Med.
164:1791-1796[Abstract/Free Full Text].
|
| 4.
|
Bone, R. C.
1993.
Gram-negative sepsis: a dilemma of modern medicine.
Clin. Microbiol. Rev.
6:57-68[Abstract/Free Full Text].
|
| 5.
|
Bramanti, T. E.,
G. G. Wong,
S. T. Weintraub, and S. C. Holt.
1989.
Chemical characterization and biologic properties of lipopolysaccharide from Bacteroides gingivalis strains W50, W83, and ATCC 33277.
Oral Microbiol. Immunol.
4:183-192[Medline].
|
| 6.
|
Ding, A. H.,
F. Porteu,
E. Sanchez, and C. F. Nathan.
1990.
Shared actions of endotoxin and taxol on TNF receptors and TNF release.
Science
248:370-372[Abstract/Free Full Text].
|
| 7.
|
Fujiwara, T.,
T. Ogawa,
S. Sobue, and S. Hamada.
1990.
Chemical, immunobiological and antigenic characterizations of lipopolysaccharides from Bacteroides gingivalis strains.
J. Gen. Microbiol.
136:319-326[Abstract/Free Full Text].
|
| 8.
|
Galanos, C.,
M. A. Freudenberg, and W. Reutter.
1979.
Galactosamine-induced sensitization to the lethal effects of endotoxin.
Proc. Natl. Acad. Sci. USA
75:5939-5943.
|
| 9.
|
Galanos, G.,
O. Lüderitz, and O. Westphal.
1969.
A new method for the extraction of R lipopolysaccharides.
Eur. J. Biochem.
9:245-249[Medline].
|
| 10.
|
Golenbock, D. T.,
R. Y. Hampton,
N. Qureshi,
K. Takayama, and C. R. H. Raetz.
1991.
Lipid A-like molecules that antagonize the effects of endotoxinson human monocytes.
J. Biol. Chem.
266:19490-19489[Abstract/Free Full Text].
|
| 11.
|
Hayes, M. P.,
S. L. Freemann, and R. P. Donnelly.
1995.
IFN- priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and mRNA stability.
Cytokine
7:427-435[Medline].
|
| 12.
|
Joiner, K. A.,
K. P. W. McAdam, and D. L. Kasper.
1982.
Lipopolysaccharides from Bacteroides fragilis are mitogenic for spleen cells from endotoxin responder and nonresponder mice.
Infect. Immun.
36:1139-1145[Abstract/Free Full Text].
|
| 13.
|
Kirikae, F.,
T. Kirikae,
N. Qureshi,
K. Takayama,
D. C. Morrison, and M. Nakano.
1995.
CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages.
Infect. Immun.
63:486-497[Abstract].
|
| 14.
|
Kirikae, T.,
F. U. Shade,
U. Zahringer,
F. Kirikae,
H. Brade,
S. Kusumoto,
T. Kusama, and E. T. Rietschel.
1994.
The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and the cytokine induction.
FEMS Immunol. Med. Microbiol.
8:13-16[Medline].
|
| 15.
|
Kumada, H.,
Y. Haishima,
T. Umemoto, and K. Tanamoto.
1995.
Structural study on the free lipid A isolated from lipopolysaccharide of Porphyromonas gingivalis.
J. Bacteriol.
177:2098-2106[Abstract/Free Full Text].
|
| 16.
|
Kumada, H.,
S. Kondo,
T. Umemoto, and K. Hisatsune.
1993.
Chemical structure of the 2-keto-3-deoxyoctonate region of lipopolysaccharide isolated from Porphyromonas (Bacteroides) gingivalis.
FEMS Microbiol Lett.
108:75-79[Medline].
|
| 17.
|
Kumada, H.,
K. Watanabe,
T. Umemoto,
Y. Haishima,
S. Kondo, and K. Hisatsune.
1988.
Occurrence of O-phosporylated 2-keto-3-deoxyoctonate in the lipopolysaccharide of Bacteroides gingivalis.
FEMS Microbiol. Lett.
51:77-80.
|
| 18.
|
Lynn, W. A., and D. T. Golenbock.
1992.
Lipopolysaccharide antagonists.
Immunol. Today
13:271-276[Medline].
|
| 19.
|
Manthey, C. L., and S. N. Vogel.
1994.
Elimination of trace endotoxin protein from rough chemotype LPS.
J. Endotoxin Res.
1:84-91.
|
| 20.
|
Manthey, C. L., and S. N. Vogel.
1994.
Taxol: a promising endotoxin research tool.
J. Endotoxin Res.
1:189-198.
[Abstract/Free Full Text] |
| 21.
|
Moreno, E., and D. T. Berman.
1979.
Brucella abortus lipopolysaccharide is mitogenic for spleen cells of endotoxin resistant C3H/HeJ mice.
J. Immunol.
123:2915-2919[Abstract/Free Full Text].
|
| 22.
|
Morrison, D. C.,
S. J. Betz, and D. M. Jacobs.
1976.
Isolation of a lipid A bound polypeptide responsible for `LPS-initiated' mitogenesis of C3H/HeJ spleen cells.
J. Exp. Med.
144:840-846[Abstract/Free Full Text].
|
| 23.
|
Morrison, D. C.,
R. L. Danner,
C. A. Dinarello,
R. S. Munford,
C. Natanson,
M. Pollack,
J. J. Spitzer,
R. J. Ulevitch,
S. N. Vogel, and E. McSweegan.
1994.
Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction.
J. Endotoxin Res.
1:71-83.
|
| 24.
|
Morrison, D. C., and D. M. Jacobs.
1976.
Binding of polymyxin B to the lipid A portion of bacteria LPS.
Immunochemistry
13:813-818[Medline].
|
| 25.
|
Nakano, M., and H. Shinomiya.
1992.
The Lps mutational defect in C3H/HeJ mice, p. 311-328.
In
D. C. Morrison, and J. L. Ryan (ed.), Bacterial endotoxic lipopolysaccharides., vol. 1. Molecular biochemistry and cellular biology. CRC Press, Inc., Boca Raton, Fla.
|
| 26.
|
Nakano, M.,
H. Yanasu,
Y. Terada,
H. Shinomiya, and S. Saito.
1993.
LPS-induced protein phosphorylation and monokine production in calcium ionophare-stimulated or BCG-infected C3H/HeJ macrophages, p. 293-304.
In
J. Levin, C. R. Alving, R. S. Munford, and P. L. Stütz (ed.), Bacterial endotoxin: recognition and effector mechanisms. Excerpta Medica, Amsterdam, The Netherlands.
|
| 27.
|
Ogawa, T.
1993.
Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide.
FEBS Lett.
332:197-201[Medline].
|
| 28.
|
Ogawa, T.
1994.
Immunobiological properties of chemically defined lipid A from lipopolysaccharide of Porphyromonas (Bacteroides) gingivalis.
Eur. J. Biochem.
219:737-742[Medline].
|
| 29.
|
Pier, G. B.,
R. B. Markham, and D. Eardley.
1981.
Correlation of the biological responses of C3H/HeJ mice to endotoxin with the chemical and structural properties of the lipopolysaccharides from Pseudomonas aeruginosa and Escherichia coli.
J. Immunol.
127:184-191[Abstract].
|
| 30.
|
Poltrak, A.,
H. Xiaolong,
I. Smirnova,
M.-Y. Liu,
C. Van Huffel,
X. Du,
D. Birdwell,
E. Alejos,
M. Silva,
C. Galanos,
M. Freudenberg,
P. Ricciardi-Castafnoli,
B. Layton, and B. Beutler.
1998.
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
Science
282:2085-2088[Abstract/Free Full Text].
|
| 31.
|
Qureshi, N.,
K. Takayama, and R. Kurtz.
1991.
Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice.
Infect. Immun.
59:441-444[Abstract/Free Full Text].
|
| 32.
|
Qureshi, N.,
K. Takayama,
K. C. Meyers,
T. N. Kirkland,
C. A. Bush,
L. Chen,
R. Wang, and R. J. Cotter.
1991.
Chemical reduction of 3-oxo and unsaturated groups in fatty acids of diphosporyl lipid A from lipopolysaccharide of Rhodopseudomonas sphaeroides. Comparison of biological properties before and after reduction.
J. Biol. Chem.
266:6532-6538[Abstract/Free Full Text].
|
| 33.
|
Spellman, J. M., and N. D. Reed.
1979.
Immune and mitogenic responses by BALB/c, C3H/HeJ, and nude mice to Brucella abortus bacteria and lipopolysaccharide.
Infect. Immun.
24:371-378[Abstract/Free Full Text].
|
| 34.
|
Suda, Y.,
T. Kirikae,
T. Shiyama,
T. Yasukochi,
F. Kirikae,
M. Nakano,
E. T. Rietschel, and S. Kusumoto.
1995.
Macrophage activation in response to S-form lipopolysaccharides (LPS) separated by centrifugal partition chromatography from wild-type LPS: effects of the O-polysaccharide portion of LPP.
Biochem. Biophys. Res. Commun.
210:678-685[Medline].
|
| 35.
|
Sultzer, B. M., and G. W. Goodman.
1976.
Endotoxin protein: a B-cell mitogen and polyclonal activator of C3H/HeJ lymphocytes.
J. Exp. Med.
144:821-827[Abstract/Free Full Text].
|
| 36.
|
Takayama, K.,
N. Qureshi,
B. Beutler, and T. N. Kirkland.
1989.
Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide.
Infect. Immun.
57:1336-1338[Abstract/Free Full Text].
|
| 37.
|
Tanamoto, K.,
S. Azumi,
Y. Haishima,
H. Kumada, and T. Umemoto.
1997.
The lipid A moiety of Porphyromonas gingivalis lipopolysaccharide specifically mediates the activation of C3H/HeJ mice.
J. Immunol.
158:4430-4436[Abstract].
|
| 38.
|
Tanner, A.
1991.
Microbial succession in the development of periodontal disease, p. 13-25.
In
S. Hamada, S. C. Holt, and J. R. McGhee (ed.), Periodontal disease: pathogens and host immune responses. Quintessence, Tokyo, Japan.
|
| 39.
|
Wannemuehler, M. J.,
S. M. Michalek,
M. Jirillo,
S. I. Williamson,
M. Hirasawa, and J. R. McGhee.
1984.
LPS regulation of the immune responses: Bacteroides endotoxin induces mitogenic, polyclonal, and antibody responses in classical LPS responsive but not C3H/HeJ mice.
J. Immunol.
133:299-305[Abstract].
|
| 40.
|
Westphal, O., and O. Lüderitz.
1954.
Chemische Erforschung von Lipopolysacchariden Gram negativer Bakterien.
Angew. Chem.
66:407-417.
|
| 41.
|
Zambon, J. J.,
S. Grossi,
R. Dunford,
V. I. Haraszthy,
H. Preus, and R. J. Genco.
1994.
Epidemiology of subgingival bacterial pathogens in periodontal disease, p. 3-12.
In
R. J. Genco, S. Hamada, T. Lehner, J. McGhee, and S. Mergenhagen (ed.), Molecular pathogenesis of periodontal disease. American Society for Microbiology, Washington, D.C.
|
Infection and Immunity, April 1999, p. 1736-1742, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sepulcre, M. P., Alcaraz-Perez, F., Lopez-Munoz, A., Roca, F. J., Meseguer, J., Cayuela, M. L., Mulero, V.
(2009). Evolution of Lipopolysaccharide (LPS) Recognition and Signaling: Fish TLR4 Does Not Recognize LPS and Negatively Regulates NF-{kappa}B Activation. J. Immunol.
182: 1836-1845
[Abstract]
[Full Text]
-
Diya Zhang, , Lili Chen, , Shenglai Li, , Zhiyuan Gu, , Jie Yan,
(2008). Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1{beta}, TNF-{alpha} and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immunity
14: 99-107
[Abstract]
-
Domon, H., Honda, T., Oda, T., Yoshie, H., Yamazaki, K.
(2008). Early and preferential induction of IL-1 receptor-associated kinase-M in THP-1 cells by LPS derived from Porphyromonas gingivalis. J. Leukoc. Biol.
83: 672-679
[Abstract]
[Full Text]
-
Mayer, A. K., Muehmer, M., Mages, J., Gueinzius, K., Hess, C., Heeg, K., Bals, R., Lang, R., Dalpke, A. H.
(2007). Differential Recognition of TLR-Dependent Microbial Ligands in Human Bronchial Epithelial Cells. J. Immunol.
178: 3134-3142
[Abstract]
[Full Text]
-
Hashimoto, M., Tawaratsumida, K., Kariya, H., Kiyohara, A., Suda, Y., Krikae, F., Kirikae, T., Gotz, F.
(2006). Not Lipoteichoic Acid but Lipoproteins Appear to Be the Dominant Immunobiologically Active Compounds in Staphylococcus aureus.. J. Immunol.
177: 3162-3169
[Abstract]
[Full Text]
-
Hashimoto, M., Tawaratsumida, K., Kariya, H., Aoyama, K., Tamura, T., Suda, Y.
(2006). Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components. Int Immunol
18: 355-362
[Abstract]
[Full Text]
-
Mancuso, G., Midiri, A., Biondo, C., Beninati, C., Gambuzza, M., Macri, D., Bellantoni, A., Weintraub, A., Espevik, T., Teti, G.
(2005). Bacteroides fragilis-Derived Lipopolysaccharide Produces Cell Activation and Lethal Toxicity via Toll-Like Receptor 4. Infect. Immun.
73: 5620-5627
[Abstract]
[Full Text]
-
Dixon, D.R., Darveau, R.P.
(2005). Lipopolysaccharide Heterogeneity: Innate Host Responses to Bacterial Modification of Lipid A Structure. JDR
84: 584-595
[Abstract]
[Full Text]
-
Asai, Y., Hashimoto, M., Fletcher, H. M., Miyake, K., Akira, S., Ogawa, T.
(2005). Lipopolysaccharide Preparation Extracted from Porphyromonas gingivalis Lipoprotein-Deficient Mutant Shows a Marked Decrease in Toll-Like Receptor 2-Mediated Signaling. Infect. Immun.
73: 2157-2163
[Abstract]
[Full Text]
-
Hashimoto, M., Asai, Y., Ogawa, T.
(2004). Separation and structural analysis of lipoprotein in a lipopolysaccharide preparation from Porphyromonas gingivalis. Int Immunol
16: 1431-1437
[Abstract]
[Full Text]
-
Zhang, X., Kluger, Y., Nakayama, Y., Poddar, R., Whitney, C., DeTora, A., Weissman, S. M., Newburger, P. E.
(2004). Gene expression in mature neutrophils: early responses to inflammatory stimuli. J. Leukoc. Biol.
75: 358-372
[Abstract]
[Full Text]
-
Murray, D. A, Wilton, J. M. A.
(2003). Lipopolysaccharide from the Periodontal Pathogen Porphyromonas gingivalis Prevents Apoptosis of HL60-Derived Neutrophils In Vitro. Infect. Immun.
71: 7232-7235
[Abstract]
[Full Text]
-
Martin, M., Schifferle, R. E., Cuesta, N., Vogel, S. N., Katz, J., Michalek, S. M.
(2003). Role of the Phosphatidylinositol 3 Kinase-Akt Pathway in the Regulation of IL-10 and IL-12 by Porphyromonas gingivalis Lipopolysaccharide. J. Immunol.
171: 717-725
[Abstract]
[Full Text]
-
Muroi, M., Ohnishi, T., Azumi-Mayuzumi, S., Tanamoto, K.-i.
(2003). Lipopolysaccharide-Mimetic Activities of a Toll-Like Receptor 2-Stimulatory Substance(s) in Enterobacterial Lipopolysaccharide Preparations. Infect. Immun.
71: 3221-3226
[Abstract]
[Full Text]
-
Martin, M., Michalek, S. M., Katz, J.
(2003). Role of Innate Immune Factors in the Adjuvant Activity of Monophosphoryl Lipid A. Infect. Immun.
71: 2498-2507
[Abstract]
[Full Text]
-
Girard, R., Pedron, T., Uematsu, S., Balloy, V., Chignard, M., Akira, S., Chaby, R.
(2003). Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J. Cell Sci.
116: 293-302
[Abstract]
[Full Text]
-
Hajishengallis, G., Martin, M., Schifferle, R. E., Genco, R. J.
(2002). Counteracting Interactions between Lipopolysaccharide Molecules with Differential Activation of Toll-Like Receptors. Infect. Immun.
70: 6658-6664
[Abstract]
[Full Text]
-
Ogawa, T., Asai, Y., Hashimoto, M., Takeuchi, O., Kurita, T., Yoshikai, Y., Miyake, K., Akira, S.
(2002). Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway. Int Immunol
14: 1325-1332
[Abstract]
[Full Text]
-
Yoshimura, A., Kaneko, T., Kato, Y., Golenbock, D. T., Hara, Y.
(2002). Lipopolysaccharides from Periodontopathic Bacteria Porphyromonas gingivalis and Capnocytophaga ochracea Are Antagonists for Human Toll-Like Receptor 4. Infect. Immun.
70: 218-225
[Abstract]
[Full Text]
-
Martin, M., Katz, J., Vogel, S. N., Michalek, S. M.
(2001). Differential Induction of Endotoxin Tolerance by Lipopolysaccharides Derived from Porphyromonas gingivalis and Escherichia coli. J. Immunol.
167: 5278-5285
[Abstract]
[Full Text]
-
Sugawara, S., Yang, S., Iki, K., Hatakeyama, J., Tamai, R., Takeuchi, O., Akashi, S., Espevik, T., Akira, S., Takada, H.
(2001). Monocytic Cell Activation by Nonendotoxic Glycoprotein from Prevotella intermedia ATCC 25611 Is Mediated by Toll-Like Receptor 2. Infect. Immun.
69: 4951-4957
[Abstract]
[Full Text]
-
Liu, Y., Wang, Y., Yamakuchi, M., Isowaki, S., Nagata, E., Kanmura, Y., Kitajima, I., Maruyama, I.
(2001). Upregulation of Toll-Like Receptor 2 Gene Expression in Macrophage Response to Peptidoglycan and High Concentration of Lipopolysaccharide Is Involved in NF-{kappa}B Activation. Infect. Immun.
69: 2788-2796
[Abstract]
[Full Text]
-
Hirschfeld, M., Weis, J. J., Toshchakov, V., Salkowski, C. A., Cody, M. J., Ward, D. C., Qureshi, N., Michalek, S. M., Vogel, S. N.
(2001). Signaling by Toll-Like Receptor 2 and 4 Agonists Results in Differential Gene Expression in Murine Macrophages. Infect. Immun.
69: 1477-1482
[Abstract]
[Full Text]
-
Tapping, R. I., Akashi, S., Miyake, K., Godowski, P. J., Tobias, P. S.
(2000). Toll-Like Receptor 4, But Not Toll-Like Receptor 2, Is a Signaling Receptor for Escherichia and Salmonella Lipopolysaccharides. J. Immunol.
165: 5780-5787
[Abstract]
[Full Text]